In This Section

Program

Friday, January 21, 2022

Welcome and Introduction 
7-7:15 p.m.

Opening Keynote Address 
7:15-8 p.m. 

Introduction of Keynote Speaker 
Timothy Rebbeck, Dana Farber Cancer Institute, Harvard T.H. Chan School of  Public Health, Boston, Massachusetts

Title to be announced 
Douglas R. Lowy, National Cancer Institute, Bethesda, Maryland 

Opening Reception  
8-9:30 p.m.

Saturday, January 22, 2022

Continental Breakfast 
7-8 a.m. 

Plenary Session 1: What Will Cancer Prevention and Early Detection Look like in 2041? 
8-9:30 a.m.   
Session Chair: Timothy Rebbeck, Dana Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 

New concepts in precision prevention 
Timothy Rebbeck

Title to be announced  
Lily H. Peng, Google Health, Palo Alto, California

Title to be announced 
Rebecca R. Richards Kortum, Rice University, Houston, Texas


Break 
10-10:30 a.m.  


Plenary Session 2:  Defining a Molecular Basis for Cancer Prevention and Early Detection 
10:30 a.m.-12 p.m. 
Session Chair: Luis A. Diaz, Jr., Memorial Sloan-Kettering Cancer Center, New York, New York 

Title to be announced  
Nickolas Papadopoulos, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland 

Title to be announced  
Daniel D. De Carvalho, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada   


Boxed Lunch 
12-1 p.m. 

Panel Discussion: How Can We Merge Novel Technologies with Knowledge of Cancer Mechanisms to Improve Early Detection of Cancer? 
12:15-1:15 p.m. 
Moderator: Raymond N. DuBois, The Medical University of South Carolina, Charleston, South Carolina

Panelists:  

Joshua LaBaer, The Biodesign Institute at Arizona State University, Tempe, Arizona 

Sudhir Srivastava, National Cancer Institute, Bethesda, Maryland 

Victor E. Velculescu, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland


Break 
1:15-1:45 p.m. 

Plenary Session 3: Preneoplastic Conditions as a Model for Early Detection 
1:45-3:45 p.m. 
Session Chair: Philip Kantoff, Memorial Sloan-Kettering Cancer Center, New York, New York

Title to be announced  
Irene M. Ghobrial, Dana-Farber Cancer Institute, Boston, Massachusetts

Title to be announced  
Peter J. Campbell, Wellcome Sanger Institute, Cambridge, England  

Title to be announced  
Veronica Rotemberg, Memorial Sloan Kettering Cancer Center, New York, New York


Break 
3:45-4:15 p.m. 
Plenary Session 4:  Innovative Approaches for Implementation – Community, Regulatory, and Operational  
4:15-6:15 p.m. 
Session Chair: Ernest T. Hawk, The University of Texas MD Anderson Cancer Center, Houston, Texas

Precision prevention in high-risk individuals: The example of Lynch syndrome 
Eduardo Vilar-Sanchez, The University of Texas MD Anderson Cancer Center, Houston, Texas 

Title to be announced  
Ruth Rechis, The University of Texas MD Anderson Cancer Center, Houston, Texas  

Title to be announced  
Derek M. Griffith, Georgetown University, Washington, DC 


Spotlight on Proferred Papers I 
6:30-7:30 p.m. 
Session Chair:  Philip E. Castle, National Cancer Institute, Bethesda, Maryland

Poster Session / Reception 
7:30-9:30 p.m. 

SUNDAY, JANUARY 23, 2022 

Continental Breakfast   
7-8 a.m. 

Keynote Address 
8-9 a.m. 

Introduction of Keynote Speaker 
Philip Kantoff, Memorial Sloan-Kettering Cancer Center, New York, New York

Title to be announced 
Minetta Liu, Mayo Clinic, Rochester, Mayo Clinic College of Medicine and Science, Rochester, Minnesota  


Break 
8:45-9 a.m. 

Plenary Session 5: Prevention and Interception 
9-11 a.m.  
Session Chair: Luis A. Diaz, Jr., Memorial Sloan-Kettering Cancer Center, New York, New York 

Title to be announced 
Mary (Nora) L. Disis, University of Washington, Seattle, Washington

Title to be announced  
Ruth D. Etzioni, Fred Hutchinson Cancer Research Center, Seattle, Washington


Boxed Lunch 
11 a.m.-12 p.m. 

Spotlight on Proferred Papers II 
11:15 a.m.-12:15 p.m. 
Moderator: Phillip Kantoff, Memorial Sloan-Kettering Cancer Center, New York, New York 

Break 
12:15-12:30 p.m. 

Plenary Session 6:  Technological Advances and Their Application in Early Detection  
This session is dedicated to the Work and Life of Sanjiv Sam Gambhir, MD, PhD 
12:30-2 p.m. 
Session Chair:  Sangeeta Bhatia, Massachusetts Institute of Technology, Cambridge, Massachusetts 

Title to be announced  
Sangeeta Bhatia

Title to be announced 
Regina Beets-Tan, Netherlands Cancer Institute, Amsterdam, Netherlands 


Closing Remarks 
2-2:15 p.m. 

Luis A. Diaz, Jr., Memorial Sloan-Kettering Cancer Center, New York, New York